References
- Amidon GL, Lennernas H, Shah VP, Crison JR. (1995). A Theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–20.
- Robinson JR. (1996). Semi-solid formulations for oral drug delivery. Bull Tech Gattefosse, 89:11–3.
- Kommuru TR, Gurley B, Khan MA, Reddy IK. (2001). Self emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm, 21:233–46.
- Aungst BJ. (1993). Novel formulations strategies for improving oral bioavailability of drugs with poor permeability or presystemic metabolism. J Pharm Sci, 82:979–87.
- Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm, 66:227–43.
- Pouton CW. (1997). Formulation of self emulsifying drug delivery systems. Adv Drug Deliv Rev, 25:47–58.
- Constantinides PP. (1995). Lipid microemulsion for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res, 12:1561–72.
- Pouton CW. (2000). Lipid formulations for oral administrations of drugs: Non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci, 11:S93–8.
- Gershanik T, Benita S. (2000). Self dispersing lipid formulations for improving oral absorption of lipophillic drugs. Eur J Pharm Biopharm, 50:179–88.
- Humberstone AJ, Charman WN. (1997). Lipid vehicles for the drug delivery of poorly water soluble drugs. Adv Drug Deliv Rev, 25:103–28.
- Wei H, Löbenberg R. (2006). Biorelevant dissolution media as a predictive tool for glyburide a class II drug. Eur J Pharm Sci, 29:45–52.
- Neuvonen PJ, Kivisto KT. (1991). The effects of magnesium hydroxide on the absorption and efficacy of two glibenclamide preparations. Br J Clin Pharmacol, 32:215–20.
- Löbenberg R, Amidon GL. (2003). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm, 50:3–12.
- Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. (2004). Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm, 30:525–34.
- Tashtoush BM, Al-Qashi ZS, Najib NM. (2004). In vitro and in vivo evaluation of glibenclamide in solid dispersion systems. Drug Dev Ind Pharm, 30:601–7.
- Vrana A, Andrysek T. (2001). The effect of particle size on bioavailability in cyclosporine preparations based on submicron dispersions. Biomed Pap, 145:9–15.
- Singh SK, Verma PRP, Razdan BK. (2009). Development and characterization of carvedilol loaded selfmicroemulsifying drug delivery system. Clin Res Regul Aff, 26:50–64.
- Singh SK, Verma PRP, Razdan BK. (2009). Development and characterization of lovastatin loaded selfmicroemulsifying drug delivery system. Pharm Dev Technol, DOI: 10.3109/10837450903286537.
- Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. (1998). Formulation design and bioavailability assessment of lipidic self emulsifying formulations of halofantrine. Int J Pharm, 167:155–64.
- Iranloye TA, Pilpel N, Groves MJ. (1983). Some factors affecting the droplet size and charge of dilute oil-in-water emulsions prepared by self-emulsification. J Dispers Sci Technol, 4:109–21.
- Gershanik T, Benzeno S, Benita S. (1998). Interaction of the self-emulsifying lipid drug delivery system with mucosa of everted rat intestine as a function of surface charge and droplet size. Pharm Res, 15:863–9.
- Tang JL, Sun J, He ZH. (2007). Self-emulsifying drug delivery system: Strategies for improving oral delivery of poorly soluble drugs. Curr Drug Ther, 2:85–93.
- Chandak AR, Verma PRP. (2008). Development and evaluation of HPMC based matrices for transdermal patches of tramadol. Clin Res Regul Aff, 25:1–18.
- O'Driscoll CM. (2002). Lipid based formulations for intestinal lymphatic delivery. Eur J Pharm Sci, 15:405–15.
- Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P, . (2000). Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci, 10:311–22.
- Barker SA, Yap SP, Yuen KH, McCoy CP, Murphy JR, Craig DQM. (2003). An investigation into the structure and bioavailability of α-tocopherol dispersions in Gelucire 44/14. J Control Release, 91:477–88.
- Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. (1995). Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusions compounds and PEG solid dispersions. Int J Pharm, 123:53–63.